Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes

By Kanazawa S.   Peterlin B.M.  

International Immunology, Vol. 13, Iss. 7, 2001-07 ,pp. : 951-958

Oxford University Press

Access to resources Recommend Favorite

IgA production in MHC class II-deficient mice is primarily a function of B-1a cells

By Snider D.  

International Immunology, Vol. 11, Iss. 2, 1999-02 ,pp. : 191-198

Oxford University Press

Access to resources Recommend Favorite

The MHC class II transactivator: prey and hunter in infectious diseases

By Accolla R.S.   De Lerma Barbaro A.   Mazza S.   Casoli C.   De Maria A.   Tosi G.  

Trends in Immunology, Vol. 22, Iss. 10, 2001-10 ,pp. : 560-563

Elsevier

Access to resources Recommend Favorite

Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells

By Chou Shiuh-Dih   Khan A. Nazmul H.   Magner William J.   Tomasi Thomas B.  

International Immunology, Vol. 17, Iss. 11, 2005-11 ,pp. : 1483-1494

Oxford University Press

Access to resources Recommend Favorite

MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?

By Jabrane-Ferrat N.  

International Immunology, Vol. 15, Iss. 4, 2003-04 ,pp. : 467-475

Oxford University Press

Access to resources Recommend Favorite